Maddi Hebebrand, MC, Associate Editor

Co-chairs Jonathan Silverberg, MD, PhD, MPH, and Raj Chovatiya, MD, PhD, MSCI, gave insight into what attendees can look forward to at this year's meeting.

Discover the latest breakthroughs in atopic dermatitis treatment and expert insights from the RAD dermatology conference in Nashville.

Zasocitinib emerges as a promising oral therapy for psoriasis and psoriatic arthritis, showcasing superior selectivity and safety compared to traditional JAK inhibitors.

Jonathan Silverberg, MD, PhD, MPH, walks through what to look out for in AD management.

Sagimet Biosciences reveals denifanstat's promising phase 3 results, offering a novel oral treatment for moderate to severe acne with significant efficacy.

Jonathan Silverberg, MD, PhD, MPH, shares his insights on treating and managing CHE.

Explore cutting-edge insights and networking opportunities at this year's Fall Clinical Dermatology Conference for PAs and NPs, focusing on dermatology education and innovative treatments.

Clinicians learn to navigate salary negotiations and contracts effectively, focusing on value and strategic insights for career empowerment.

Discover essential business metrics for PAs in dermatology, empowering practice ownership and driving sustainable growth through data-driven strategies.

Ben Lockshin, MD, FAAD, covered ways in which GLP-1 RAs can be utilized when treating psoriatic disease.

Chronic hand eczema poses diagnostic challenges and impacts quality of life, but emerging JAK inhibitors offer promising new treatment options.

At the Fall Clinical PA/NP 2025 meeting, James Del Rosso, DO, spoke about recently approved therapies like JAKis for alopecia, biologics for AD, and tirbanibulin for AKs.

Kristine Kucera, PA-C, MPAS, DHS, highlights the enduring importance of traditional systemic therapies in dermatology, emphasizing their clinical utility amidst emerging treatments.

Discover practical strategies for enhancing efficiency, focusing on workflow optimization, teamwork, and clinician well-being for better patient care.

Scott Jackson, MD, explores complex drug-induced skin reactions, emphasizing diagnostic challenges and the importance of thorough medication reviews for effective treatment.

Lauren Miller, PA-C, MPAS, highlights the vital role of mentorship in dermatology, emphasizing its impact on professional growth and patient care at the Fall Clinical conference.

Jamie Restivo, PA-C, a board-certified dermatology physician assistant and current president of the Pennsylvania Dermatology Physician Assistants (PDPA), gave insights into the PA perspective.

Explore the latest insights in dermatology at the Fall Clinical PA/NP Conference, featuring experts like James Del Rosso, DO, and networking opportunities for PA NPs.

Discover expert insights and practice management tips at the Fall Clinical PA/NP Conference in Orlando, featuring top dermatology professionals.

Explore the top headlines of the week including insights on regulatory updates, expert pearls, and more.

Jonathan Silverberg, MD, PhD, MPH, talks about when and how to take itch into consideration when choosing a therapy for AD.

Renata Block, PA-C, speaks with patient advocate Brittanny Groover on her experience, how to educate young patients, and understanding the psychosocial impact of melanoma.

Jonathan Silverberg, MD, PhD, MPH, shares pearls from the ADvocate1 and 2 trials examining the use of lebrikizumab for AD.

Microneedling proves more effective than microinjections for PRP therapy in treating melasma, enhancing patient outcomes and satisfaction.

Jonathan Silverberg, MD, PhD, MPH, talks about therapies used for AD, including nemolizumab.

Explore the significant mental health and socioeconomic impacts of atopic dermatitis and alopecia areata, revealing urgent needs for better support and awareness.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Discover the promising efficacy and safety of combining platelet-rich plasma with fractional laser therapy for treating vitiligo in adults.

FDA approves Arcutis' roflumilast foam, a groundbreaking treatment for plaque psoriasis, offering a steroid-free, effective solution for patients aged 12 and older.